Cystathionine-β-synthase-derived hydrogen sulfide contributes to glucocorticoid-induced depressive-like behaviors in rats by modulating neuroinflammation
Ying Zhao , Shi-Yi Ye , Long Li , Yi-Heng Li , Jin-Qiong Zhan , Li-Li Zheng , Yuan-Jian Yang , Bo Wei , Shu-Zhen Jiang , Xiao-Yan Cheng
{"title":"Cystathionine-β-synthase-derived hydrogen sulfide contributes to glucocorticoid-induced depressive-like behaviors in rats by modulating neuroinflammation","authors":"Ying Zhao , Shi-Yi Ye , Long Li , Yi-Heng Li , Jin-Qiong Zhan , Li-Li Zheng , Yuan-Jian Yang , Bo Wei , Shu-Zhen Jiang , Xiao-Yan Cheng","doi":"10.1016/j.brainresbull.2025.111549","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Long-term treatment of glucocorticoids (GCs) may lead to depressive adverse effect. Hydrogen sulfide (H<sub>2</sub>S) is implicated in the pathophysiology of depression and has an ability to modulate neuroinflammatory, which underlies the pathogenesis of depression. The aim of this study was to investigate whether H<sub>2</sub>S signaling contributed to dexamethasone (DEX)-induced depression in a rat model.</div></div><div><h3>Methods</h3><div>Rats were subcutaneously injected with DEX (5 mg/kg) once daily for 28 days. The behavioral performances were examined by social interaction test (SIT), sucrose preference test (SPT), open field test (OFT) and forced swimming test (FST). The expressions of cystathionine-β-synthase (CBS) and inducible nitric oxide synthase (iNOS) were measured by western blotting and immunofluorescence assay. Cytokine levels were examined by enzyme-linked immunosorbent assay (ELISA) kits. The morphological changes of neurons in rat hippocampal CA1 region were observed using H.E. staining.</div></div><div><h3>Results</h3><div>We found that chronic DEX treatment caused obvious depressive-like behaviors in rats, and the levels of H<sub>2</sub>S and CBS, the predominant H<sub>2</sub>S-producing enzyme in the brain, were significantly reduced in the hippocampus of DEX-treated rats. Overexpression of CBS increased the levels of H<sub>2</sub>S and CBS protein in the hippocampus and attenuated the depressive-like behaviors in DEX-treated rats, whereas inhibition of CBS activity abolished the beneficial effects of CBS elevation. Mechanismly, chronic DEX treatment reduced the levels of anti-inflammatory cytokines IL-10 and TGF-β, increased the levels of pro-inflammatory cytokines IL-1β and TNF-α, and caused neuronal damage in the hippocampus of rats, while CBS overexpression reversed these changes caused by DEX treatment. Furthermore, the increased protein level of iNOS, a marker of microglia polarizing to M1 phenotype to produce pro-inflammatory effects, in the hippocampus of DEX-treated rats was also restored by CBS overexpression.</div></div><div><h3>Conclusion</h3><div>These results indicate that CBS-derived H<sub>2</sub>S contributes to glucocorticoid-induced depressive-like behaviors in rats, and the effects of H<sub>2</sub>S signaling might involve the regulation of neuroinflammation.</div></div>","PeriodicalId":9302,"journal":{"name":"Brain Research Bulletin","volume":"231 ","pages":"Article 111549"},"PeriodicalIF":3.7000,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain Research Bulletin","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0361923025003612","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Long-term treatment of glucocorticoids (GCs) may lead to depressive adverse effect. Hydrogen sulfide (H2S) is implicated in the pathophysiology of depression and has an ability to modulate neuroinflammatory, which underlies the pathogenesis of depression. The aim of this study was to investigate whether H2S signaling contributed to dexamethasone (DEX)-induced depression in a rat model.
Methods
Rats were subcutaneously injected with DEX (5 mg/kg) once daily for 28 days. The behavioral performances were examined by social interaction test (SIT), sucrose preference test (SPT), open field test (OFT) and forced swimming test (FST). The expressions of cystathionine-β-synthase (CBS) and inducible nitric oxide synthase (iNOS) were measured by western blotting and immunofluorescence assay. Cytokine levels were examined by enzyme-linked immunosorbent assay (ELISA) kits. The morphological changes of neurons in rat hippocampal CA1 region were observed using H.E. staining.
Results
We found that chronic DEX treatment caused obvious depressive-like behaviors in rats, and the levels of H2S and CBS, the predominant H2S-producing enzyme in the brain, were significantly reduced in the hippocampus of DEX-treated rats. Overexpression of CBS increased the levels of H2S and CBS protein in the hippocampus and attenuated the depressive-like behaviors in DEX-treated rats, whereas inhibition of CBS activity abolished the beneficial effects of CBS elevation. Mechanismly, chronic DEX treatment reduced the levels of anti-inflammatory cytokines IL-10 and TGF-β, increased the levels of pro-inflammatory cytokines IL-1β and TNF-α, and caused neuronal damage in the hippocampus of rats, while CBS overexpression reversed these changes caused by DEX treatment. Furthermore, the increased protein level of iNOS, a marker of microglia polarizing to M1 phenotype to produce pro-inflammatory effects, in the hippocampus of DEX-treated rats was also restored by CBS overexpression.
Conclusion
These results indicate that CBS-derived H2S contributes to glucocorticoid-induced depressive-like behaviors in rats, and the effects of H2S signaling might involve the regulation of neuroinflammation.
期刊介绍:
The Brain Research Bulletin (BRB) aims to publish novel work that advances our knowledge of molecular and cellular mechanisms that underlie neural network properties associated with behavior, cognition and other brain functions during neurodevelopment and in the adult. Although clinical research is out of the Journal''s scope, the BRB also aims to publish translation research that provides insight into biological mechanisms and processes associated with neurodegeneration mechanisms, neurological diseases and neuropsychiatric disorders. The Journal is especially interested in research using novel methodologies, such as optogenetics, multielectrode array recordings and life imaging in wild-type and genetically-modified animal models, with the goal to advance our understanding of how neurons, glia and networks function in vivo.